Status:
COMPLETED
Texture Analysis for Postmenopausal Osteoporosis
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Osteoporosis
Osteopenia
Eligibility:
FEMALE
59+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method...
Detailed Description
The study proposed in this application is a part of a larger project entitled "Clinical utility of radiographic texture analysis in diagnosing and treating osteoporosis". The overall goal of the large...
Eligibility Criteria
Inclusion
- The study will enroll 40 postmenopausal women with a T score \< -2 either at the lumbar spine or the femoral neck: 20 who decide to begin anti-resorptive therapy (treated group), and 20 women who decline such therapy (control group). We will attempt to match the patients and the controls for T score (within 0.3) and age (within 5 years).
- All study participants will be:
- at least 3 years past the last menstrual period,
- not on HRT, Raloxifene or calcitonin for at least 6 months.
Exclusion
- All study participants will not be on bisphosphonates during the previous 12 months.
- Women with secondary causes of osteoporosis will be excluded.
Key Trial Info
Start Date :
July 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00145977
Start Date
July 1 2001
End Date
December 1 2009
Last Update
September 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637